Literature DB >> 33513346

Subversion of calreticulin exposure as a strategy of immune escape.

Guido Kroemer1, Laurence Zitvogel2.   

Abstract

In this issue, Lin et al. report that, in malignant cells, stanniocalcin-1 (STC1) prevents the cell surface exposure of the "eat me" signal calreticulin, thereby avoiding phagocytosis by antigen-presenting cells. STC1 overexpression joins an arsenal of mechanisms through which tumor cells suppress calreticulin exposure and escape from immunosurveillance.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Year:  2021        PMID: 33513346     DOI: 10.1016/j.ccell.2021.01.014

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  3 in total

1.  Bortezomib Induces Immunogenic Cell Death in Multiple Myeloma.

Authors:  Laurence Zitvogel; Guido Kroemer
Journal:  Blood Cancer Discov       Date:  2021-05-26

Review 2.  Stanniocalcin 2 (STC2): a universal tumour biomarker and a potential therapeutical target.

Authors:  Shuo Qie; Nianli Sang
Journal:  J Exp Clin Cancer Res       Date:  2022-05-02

3.  Calreticulin as an Adjuvant In Vivo to Promote Dendritic Cell Maturation and Enhance Antigen-Specific T Lymphocyte Responses against Melanoma.

Authors:  Zheng Gong; Ming Chen; Jie Miao; Chao-Jie Han; Qiao Zhong; Fang-Yuan Gong; Xiao-Ming Gao
Journal:  J Immunol Res       Date:  2022-08-09       Impact factor: 4.493

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.